| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bde8ecff5b221d2df08e4fde167a2c63 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 |
| filingDate |
1983-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1984-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39691284b307092ff596766f73e716e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c292cc93ba1ed37ee41c4dda8988b039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_112f893d654a460278a6c7db1f405914
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70c5f4bdac3f5685ef3326468e656567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d0317c21eeb3929c2575f249009aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05204019698291d619e9428c62226d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0ba7d14e33524bcd254a7c1ccf6c0c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0419578f35002fdfb572c8646268424 |
| publicationDate |
1984-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4470993-A |
| titleOfInvention |
Therapeutical use of known 5-aminomethyl oxazolidine-2-one derivatives |
| abstract |
Method of treating the central nervous system troubles such as the Parkinson's disease and the senescence troubles, generally treated by the B type monoamine oxidase inhibitors, which comprises administering internally to a human being requiring such treatment a therapeutically effective amount of N-aryl 5-aminomethyl oxazolidine-2-one derivatives. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0334674-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0334674-A3 |
| priorityDate |
1982-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |